UCLA researchers are working on a single test that can detect pathogens beyond COVID-19. Eleazar Eskin, one of the faculty members leading the project, said a current diagnostic test for COVID-19, ...

Effects of initiating in-office germline testing in safety net clinic patients with epithelial ovarian cancer. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does ...

FOSTER CITY, Calif., May 30, 2025 /PRNewswire/ -- Adela, Inc., an innovator in blood testing for molecular residual disease (MRD) monitoring and early cancer detection through a proprietary ...

UCLA Health is joining a new effort to increase the ability to quickly respond to emerging pathogens by creating the capability to detect all existing and new respiratory RNA viruses in a single test.

We think Keysight Technologies is the leader in communications testing and measurement solutions, and offers a vendor-agnostic way to invest in the rapidly growing 5G and high-speed networking markets ...